InvestorsHub Logo
Followers 106
Posts 10171
Boards Moderated 0
Alias Born 02/25/2003

Re: C504 post# 38310

Thursday, 04/15/2021 12:47:53 PM

Thursday, April 15, 2021 12:47:53 PM

Post# of 44690
..correct on the wording ... even today Relief stated they will be filing.. below is a post from today on ya-h00 that explains my earlier view.. and adds to the confusion.. ;)

Post by Relief 2 hours ago

The EUA application has been ongoing since it was originally filed back in September. No new application needed if you listen to Dr. J. In December, the request was denied as submitted based on the small patient set.

Understandable. Dr. J continued to work with the FDelay on what was an appropriate sample size. The RCT trial was designed with the approval of the FDA. The endpoints were approved by the FDA. We provided the agreed upon sample size and the results met the endpoints across ALL patients and sites at 28 and 60 days.

Incredible. No better therapeutic to help critical C19 patients. The FDelay is well aware of what has been accomplished by Zyesami from EAP and RCT patient results.

Soon the world will know. Please relax, the EUA is already under consideration by the FDelay for this amazing therapeutic. Tick tock, buy more of this stock while you wait.

~ Money Making Money ~